No, not a test to see if you have 3D herpes, or any other kind, but a test to study herpes simplex virus in vivo. By the way, thanks to your mom for sending this in. Apparently she's an expert on herpes.
Anyway, Dr. Anke Burger-Kentischer of the Institut für Grenzflächenverfahrenstechnik at Stuttgart, along with her team and the cell systems department recently developed a three-dimensional infection model for the herpes virus. Because herpes flares up with cold sores on the lip and then hides in a lysogenic phase in the nerve cells, it is difficult to study. This new model makes it easier to detect if the virus is really gone or just dormant. Like similar news previously reported here, this approach replaces animal testing with a more useful and less cruel alternative.
Dr. Burger-Kentischer believes that the model can be adapted to study another member of alphaherpesvirinae, the varicella zoster virus, which causes shingles and chicken pox. Of course, you all received your vaccination for that, right? I know the vaccine has gelatin in it and is created using chicken embryos, but besides saving human lives, vaccination removes the need for animal testing and research using animal products. If you want to make a change, go to the crux of the issue and press for vegan vaccines. In the meantime, circle circle dot dot...
Showing posts with label virus. Show all posts
Showing posts with label virus. Show all posts
18 July 2011
23 September 2009
Eggless Swine Flu Vaccines coming to Europe
This is an update on a story being followed here. I was perusing the Baxter website for news, and found this out-of-date update. Deciding to do some minor journalism, I emailed them, and just got a reply from Karoline Traschler, Project Marketing Manager for Global Marketing Vaccines:
The last sentence is of concern, being stateside and all. I replied asking for clarification, but I'd imagine it'd have to do with the stricter drug safety regulations here (thanks a lot, thalidamide!). I'll keep you posted.
We thank you for your interest in our H1N1 vaccine. We expect European licensure by end of September. We have to inform you that it will not be available on the US market.
The last sentence is of concern, being stateside and all. I replied asking for clarification, but I'd imagine it'd have to do with the stricter drug safety regulations here (thanks a lot, thalidamide!). I'll keep you posted.
Subscribe to:
Posts (Atom)
